Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs >

Nektar Therapeutics (NKTR)

NKTR RSS Feed
Add NKTR Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 9/16/2014 5:11:10 PM - Followers: 31 - Board type: Free - Posts Today: 0
http://www.nektar.com

http://finance.yahoo.com/q?s=NKTR


Nektar Therapeutics, a biopharmaceutical company, develops various drug products and product candidates using its proprietary drug delivery technologies. Its technology platforms comprise PEGylation Technology designed to enhance the performance of various drug classes, including macromolecules, small molecules, and other drugs; and Pulmonary Technology, which includes technologies for drug formulation, powder processing, powder filling, and packaging, as well as dry powder inhaler devices and liquid nebulizer devices. The company's technologies are used in 10 approved products; 3 partner programs that have been filed for with the FDA; and 12 development programs in human clinical trials. Its partnered products include Tobramycin inhalation powder, a Phase III clinical product for treating lung infections; NKTR-061, a Phase II clinical product for gram-negative pneumonias; Ciprofloxacin Inhalation Powder, a Phase II clinical product for lung infections; Pulmonary dronabinol, a Phase II product for migraine; and Exubera Inhalation Powder for adult type 1 and type 2 diabetes. The company's partnered product portfolio also comprises Neulasta for neutropenia; PEGASY for Hepatitis-C; Somavert for Acromegaly; PEG-INTRON for Hepatitis-C; Macugen for age-related macular degeneration; CIMZIA for Crohn's disease; MIRCERA for renal anemia and chronic kidney disease; CIMZIA for rheumatoid arthritis; Hematide, a Phase III product for Anemia; Macugen, a Phase II clinical trial product for diabetic macular edema and retinal vein occlusion; and CDP 791, a Phase II product for nonsmall cell lung cancer. In addition, Nektar's proprietary products include NKTR-102, a Phase II trial product for colorectal cancer; and NKTR-118, which is in Phase II clinical trials for opioid-induced constipation and other manifestations of opioid bowel dysfunction. The company was founded in 1990 and is headquartered in San Carlos, California.


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NKTR
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for NKTR
NKTR News: Nektar Presents Preclinical Study Findings for Etirinotecan Pegol (NKTR-102) in Combination with a PARP Inhibitor in BRCA1-de... 11/20/2014 09:00:00 AM
NKTR News: Quarterly Report (10-q) 11/07/2014 06:08:45 AM
NKTR News: Nektar Therapeutics Reports Financial Results for the Third Quarter of 2014 11/06/2014 04:10:00 PM
NKTR News: Statement of Changes in Beneficial Ownership (4) 11/04/2014 01:41:32 PM
NKTR News: Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Fina... 10/30/2014 08:30:00 AM
PostSubject
#55   Amikacin Inhale Shows Promising Results in Phase II Study surf1944 05/19/08 04:54:39 PM
#54   Significant Anti-Tumor Activity of NKTR-102 in Patients With surf1944 05/16/08 08:51:59 AM
#53   Nektar Therapeutics shares fall on wider-than-expected loss surf1944 05/08/08 01:28:29 PM
#52   NKTR-118 Shows Substantial Oral Bioavailability and Extended Half-Life surf1944 05/07/08 09:07:06 AM
#51   FDA Approval of Cimzia(R) for Crohn's Disease Represents surf1944 04/23/08 08:17:33 AM
#50   Additive Anti-Tumor Activity of NKTR-102 in Combination With surf1944 04/14/08 08:55:00 AM
#49   Nektar Terminates All Negotiations With Potential Partners for surf1944 04/09/08 08:39:13 AM
#48   Stay away from NKTR for now, heading to surf1944 10/18/07 08:49:49 AM
#47   Bayer HealthCare and Nektar Therapeutics Launch Global Development surf1944 08/06/07 09:43:01 AM
#45   THIS IS A DEAD BOARD toomanycrybabies 07/08/07 09:30:58 AM
#44   Cowen Sees Nektar Outperforming Market By 30%+ surf1944 06/28/07 06:18:15 PM
#43   www.horizonstudy.com you have type 2 diabetes – and are stockguard 10/17/06 09:58:35 PM
#42   UPGRADES & DOWNGRADES HISTORY stockguard 10/08/06 02:26:28 PM
#41   So does ChangeWave Biotech Investor - 7/13/06 SeriousMoney 07/13/06 05:37:06 PM
#40   InfinitiStocks.com likes NKTR serfdom 06/11/06 11:34:32 PM
#39   Nektar Gets Fast-Track for Lung Drug SeriousMoney 05/22/06 11:41:15 AM
#38   Nektar Therapeutics "buy" SeriousMoney 05/17/06 12:12:31 PM
#37   Great assessment, B. I think we've got SeriousMoney 04/20/06 11:12:55 AM
#36   Bottom line, if insurance companies decide to pay bernoulli 04/20/06 09:24:22 AM
#35   Pfizer/Nektar: Exubera to enjoy strong mid-term growth SeriousMoney 04/20/06 01:29:50 AM
#34   Bad link... try this one for AMLN [#msg-10433899] SeriousMoney 03/31/06 07:48:21 PM
#33   NEKTAR (NKTR): An interesting note about short positions SeriousMoney 03/31/06 01:29:40 PM
#32   We're on the same page on NKTR. SeriousMoney 03/29/06 02:01:16 PM
#31   NKTR painted a pretty bleak picture for this bernoulli 03/29/06 01:36:55 PM
#30   Where's the news? SeriousMoney 03/29/06 11:24:00 AM
#29   Advisory: Bear Biotech West Coast Confab to Webcast SeriousMoney 03/21/06 04:53:24 PM
#28   Loss Widens for Nektar SeriousMoney 03/01/06 03:05:09 PM
#27   Inhaling medicine removes the sting SeriousMoney 02/20/06 09:44:25 PM
#26   Local ties assist new Pfizer drug SeriousMoney 02/20/06 08:55:27 PM
#25   MICHAEL SHULMAN: Editor ChangeWave Biotech Investor SeriousMoney 02/15/06 01:05:31 PM
#24   thx, B! Toby Smith's ChangeWave Biotech reco'd SeriousMoney 02/15/06 12:57:50 PM
#23   Over the years one gets a sense of bernoulli 02/15/06 12:31:01 PM
#22   Nektar Announces That U.S. FDA Has Granted Orphan SeriousMoney 02/15/06 01:02:57 AM
#21   Merrill Lynch to Webcast Nektar Corporate Presentation SeriousMoney 02/01/06 10:56:18 PM
#20   Diabetics get some good news: FDA approves inhaled SeriousMoney 01/28/06 02:36:05 PM
#19   Great homework, B! SeriousMoney 01/28/06 12:04:03 PM
#18   Good Morning, didn't know if you had seen bernoulli 01/28/06 09:34:43 AM
#17   NEKTAR UPDATE - 1/27/06 SeriousMoney 01/27/06 07:27:10 PM
#16   Why the sell off on the news? SeriousMoney 01/27/06 04:11:42 PM
#15   Novo Nordisk Sales Climb SeriousMoney 01/27/06 04:07:28 PM
#14   Talk about the power of suggestion... or me-too-ism! SeriousMoney 01/27/06 02:12:27 PM
#13   Took slugs of MAR 22.5 & MAY 25. SeriousMoney 01/27/06 10:36:52 AM
#12   Looks like I am a day late and bernoulli 01/27/06 04:48:04 AM
#11   Gonna be a big pop tomorrow a.m. SeriousMoney 01/26/06 10:57:27 PM
#10   Insulin Firms Waiting to Inhale SeriousMoney 01/26/06 10:50:08 PM
#9   Inhaled Insulin Cleared in Europe SeriousMoney 01/26/06 10:45:24 PM
#8   Nektar Up on Pfizer Exubera Buyout SeriousMoney 01/17/06 11:11:14 AM
#7   Pfizer to Buy Inhaled-Insulin Rights SeriousMoney 01/13/06 01:13:58 AM
#6   Toby on NKTR 12/1/005 SeriousMoney 12/02/05 04:25:47 AM
#5   Nektar Announces Third Quarter 2005 Financial Results SeriousMoney 11/11/05 07:58:19 AM
PostSubject